NON-HODGKINS LYMPHOMA
Clinical trials for NON-HODGKINS LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new NON-HODGKINS LYMPHOMA trials appear
Sign up with your email to follow new studies for NON-HODGKINS LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early trial tests new combo for tough blood cancers
Disease control CompletedThis study tested a new combination of two drugs, acalabrutinib and ACP-319, for people with B-cell cancers like non-Hodgkin's lymphoma and multiple myeloma. The main goals were to find the safest dose and see if the treatment was effective at controlling the disease. It involved…
Matched conditions: NON-HODGKINS LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Scientists search for secret to bouncing back after cancer treatment
Knowledge-focused CompletedThis study aimed to identify what helps older adults recover well after a bone marrow transplant for blood cancers like leukemia and lymphoma. Researchers measured physical ability, mental health, stress hormones, and other factors in 126 patients aged 60 and older before and aft…
Matched conditions: NON-HODGKINS LYMPHOMA
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:41 UTC